Oslo, 2 April 2024: Reference is made to the stock exchange announcement
published on 15 March 2024 by Navamedic ASA (the "Company") regarding the board
of directors' resolution to increase the Company's share capital in connection
with the exercise of employee share options. The share capital increase
pertaining to the exercised share options has now been registered with the
Norwegian Register of Business Enterprises (Nw. Foretaksregisteret). The new
share capital of the Company is NOK 12,900,254.98, divided into 17,432,777
shares, each with a nominal value of NOK 0.74.
For further information, please contact: Lars Hjarrand, CFO, Navamedic, Mobile:
+47 917 62 842 E-mail: lars.hjarrand@navamedic.com
About Navamedic ASA: Navamedic ASA is a Nordic full-service provider of high
-quality products to hospitals and through pharmacies. Navamedic meets the
specific needs of patients and consumers by leveraging its highly scalable
market access platform, leading category competence and local knowledge.
Navamedic is present in all the Nordic countries, the Baltics and Benelux, with
sales representation in the UK and Greece. Navamedic is headquartered in Oslo,
Norway, and listed on the Oslo Stock Exchange (ticker: NAVA).
For more information, please visit www.navamedic.com.
This information is subject of the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.